Dailixin is the trade name of haloperidol melitrexate tablets, and its maximum reaction after discontinuation of the drug in the somatic aspect of headache, dizziness, nausea, vomiting and other autonomic dysfunction manifestations; in the psychological aspect of the psychological aspects can be manifested as nervousness, anxiety, irritability, fear and so on, or the treatment of the original psychiatric symptoms reappeared.
Haloperidol meletriptyline tablets are compound preparations, in which haloperidol is a thiazide-type nerve blocker with anxiolytic and antidepressant effects in small doses; meletriptyline is a biphasic antidepressant with excitatory properties when applied in low doses.
Clinically the drug is not only used for the treatment of mild and moderate depression and anxiety; it is also used for the treatment of neurasthenia, psychogenic depression, depressive neurosis, insidious depression, psychosomatic disorders with anxiety and affective apathy, menopausal depression, agitation and depression in alcohol and drug addicts.
There are adverse reactions such as dizziness, restlessness, dry mouth and constipation after using the drug.
It is prohibited for those who are allergic to any of the components in the product; it is prohibited for patients with comatose state, adrenal pheochromocytoma, hematological malignancy, and untreated closed-angle glaucoma.
Use with caution in patients with organic brain damage, convulsive seizures, urinary retention, hyperthyroidism, Parkinson’s syndrome, myasthenia gravis, advanced liver disease, cardiovascular and other circulatory diseases; during the use of the drug, you should not drive or operate dangerous machines.
The drug needs to be discontinued should be in accordance with the guidance of a specialist physician program implementation, not to stop the drug suddenly or stop too quickly.